Mette Kirstine Agger
@mettekirstineagger
Director
Building scPharmaceuticals Inc. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
scPharmaceuticals Inc. was founded in 2014 and has no closure on record.
Named alongside
- Barbara M. DaltonDirector
- Christoph M. AdamsExecutive Officer, Director
- David M. MottDirector
- James M. McArthurExecutive Officer
- Sandip Kirstine AgarwalaDirector
- Sara M. NayeemDirector
At IMARA Inc.
- Andrew P. PhillipsDirector
- Anish P. PatelExecutive Officer
- Barbara G. DaltonDirector
- Barbara Kirstine DaltonDirector
- Benjamin P. HohlExecutive Officer
- Carl G. GoldfischerDirector
- Christoph M. AdamsExecutive Officer, Director
- David G. BonitaDirector
- Abhay GandhiDirector
- Abraham CeesayExecutive Officer
- Dorothy ColemanDirector
- Dorothy Kirstine ColemanDirector
- Jack KhattarDirector
- Jonathan SilversteinDirector
- Kush ParmarDirector
- Leonard Kirstine SchaefferDirector
- Abraham N. CeesayExecutive Officer
- Christoph M. AdamsExecutive Officer, Director
- David Kirstine MottDirector
- James G. McArthurExecutive Officer
- Sandip Kirstine AgarwalaDirector
- Sara Kirstine NayeemDirector
- Anne L. VanLentDirector
- Annie L. MitsakDirector
- Cayce L. DentonDirector
- Chris Kirstine SeiterExecutive Officer
- David L. MeekerDirector
- David R. MeekerDirector
- Dominick L. ColangeloDirector
- Ed L. MathersDirector
Contribution
Mette's ideas, decisions and failures appear here once this profile is claimed.
Companies
- scPharmaceuticals Inc.Pharmaceutical Preparations; filing with the SEC since 2014Director · Pharmaceuticals · Lexington, United States · Founded 2014
- IMARA Inc.Pharmaceutical Preparations; formerly IMARA Inc.; listed on Nasdaq as ELVN; filing with the SEC since 2016Director · Pharmaceuticals · CAMBRIDGE, United States · Founded 2016
- Trevi Therapeutics, Inc.Pharmaceutical Preparations; listed on Nasdaq as TRVI; filing with the SEC since 2012Director · Biotechnology · New Haven, United States
- Cydan II, Inc.Director · Biotechnology · CAMBRIDGE, United States · Founded 2017
- Tiburio Therapeutics Inc.Director · Pharmaceuticals · CAMBRIDGE, United States · Founded 2018